- Graduate School - Universidad Central De Venezue, Internal Medicine
- Medical School - University of Carabobo, Medicine
- Medical School - Westhills Community College, Medicine
Amneris Luque, M.D.
- Internal Medicine - Infectious Diseases and Geographic Medicine
- Infectious Disease
Amneris Esther Luque, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She serves as Medical Director of the HIV Program for the Parkland Health and Hospital System and as Director of the Community Prevention and Intervention Unit in UT Southwestern’s School of Health Professions, which became part of the Division of Infectious Diseases in 2020. She specializes in HIV and other infectious diseases.
Dr. Luque earned her medical degree at the Universidad de Carabobo in Valencia, Venezuela. She then completed a residency in internal medicine at the Universidad Central de Venezuela, followed by advanced training in infectious diseases through separate fellowships at the University of Rochester School of Medicine and Dentistry and the State University of New York at Stony Brook Health Sciences Center.
Certified by the American Board of Internal Medicine, Dr. Luque joined the UT Southwestern faculty in 2016. Previously, she served for 22 years at the University of Rochester Medical Center, where she was the Director of the HIV Program and a key contributor in the development of clinical guidelines and HIV education initiatives for New York State; during that time she also was an investigator for the National Institutes of Health-sponsored AIDS Clinical Trials Group at the University of Rochester.
The author of numerous research articles and invited national and international lectures, Dr. Luque focuses her current clinical studies on community-based participatory research and implementation trials for HIV disease and general infectious diseases.
She is a member of the American Academy of HIV Medicine, the American Society for Microbiology, the Infectious Diseases Society of America, the National Hispanic Medical Association, and the Venezuelan Society of Infectious Diseases.
- American Academy of HIV Medicine
- American Society for Microbiology
- Infectious Diseases Society of America
- National Hispanic Medical Association
- Venezuelan Society of Infectious Diseases
- Bridging Fellowship in Neuroimaging 2015, University of Rochester's Provost Office
- Recognition for Leadership in Improving the Health of Hispanics 2008, National Hispanic Medical Association
- Linda Laubestein Clinical Excellence Award 2002, New York State DOH AIDS Institute
- NHMA Fellowship at New York University 2000, National Hispanic Medical Association (NHMA)
- Distinguished Physician of the Year 1995, Visiting Nurse Services
- Overseas Study Scholarship (for Infectious Diseases Fellowship) 1982-1985, Fundacion Gran Mariscal de Ayacucho (Venezuelan Government Program)
- Fellowship Award to attend Magister Scientiarum Program 1979-1981, Universidad Central de Venezuela
Antiretroviral Therapy: Therapeutic Agents, Dosing, Pharmocokinetics, and Their Use in Reese and Betts' A Practical Approach to Infectious Diseases
Luque A, Cohn S, Weinberg G, and Mariuz P (2003), Philadelphia, PA, Lippincott Williams & Wilkins
- Antiretroviral Therapy: Therapeutic Agents, Dosing, Pharmocokinetics, and Their Use in Reese and Betts' A Practical Approach to Infectious Diseases
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.
Lok JJ, Hunt PW, Collier AC, Benson CA, Witt MD, Luque AE, Deeks SG, Bosch RJ AIDS (London, England) 2013 Aug 27 13 2101-10
Identifying Effective Approaches for Dissemination of Clinical Evidence--Correlation Analyses on Promotional Activities and Usage of a Guideline-Driven Interactive Case Simulation Tool in a Statewide HIV-HCV-STD Clinical Education Program.
Wang D, Le XH, Luque AE Studies in health technology and informatics 2015 216 515-9
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study.
Luque AE, Cohn SE, Park JG, Cramer Y, Weinberg A, Livingston E, Klingman KL, Aweeka F, Watts DH Antimicrobial agents and chemotherapy 2015 Apr 59 4 2094-101
Hearing function in patients living with HIV/AIDS.
Luque AE, Orlando MS, Leong UC, Allen PD, Guido JJ, Yang H, Wu H Ear and hearing 2014 Nov-Dec 35 6 e282-90
Bridging the digital divide in HIV care: a pilot study of an iPod personal health record.
Luque AE, Corales R, Fowler RJ, DiMarco J, van Keken A, Winters P, Keefer MC, Fiscella K Journal of the International Association of Providers of AIDS Care 2013 Mar-Apr 12 2 117-21
Evaluation of an Enhanced Role-Based Access Control model to manage information access in collaborative processes for a statewide clinical education program.
Le XH, Doll T, Barbosu M, Luque A, Wang D Journal of biomedical informatics 2014 Aug 50 184-95
Activation of persons living with HIV for treatment, the great study.
Fiscella K, Boyd M, Brown J, Carroll J, Cassells A, Corales R, Cross W, El'Daher N, Farah S, Fine S, Fowler R, Hann A, Luque A, Rodriquez J, Sanders M, Tobin J BMC public health 2015 15 1 1056
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
Weinberg A, Park JG, Bosch R, Cho A, Livingston E, Aweeka F, Cramer Y, Watts DH, Luque AE, Cohn SE Journal of acquired immune deficiency syndromes (1999) 2016 Feb 71 2 137-45
Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.
Mitchell C, Balkus JE, McKernan-Mullin J, Cohn SE, Luque AE, Mwachari C, Cohen CR, Coombs R, Frenkel LM, Hitti J Journal of acquired immune deficiency syndromes (1999) 2013 Feb 62 2 143-8
Mycobacterium avium-complex pericarditis: a case of unmasking immune reconstitution inflammatory syndrome.
Babu TM, Laguio M, Luque AE, Larppanichpoonphol P International journal of STD & AIDS 2014 Feb 25 2 148-51
- The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy.
- Community-Based Participatory Research/Implementation Trials
- HIV Disease
- Infectious Diseases
- Human Papillomavirus Infection and Disease in Individuals Living with HIV
- Use of Technology for Patient Activation
- Infectious Disease
Results: 1 Locations